Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based study
Objective This study defined a retrospective cohort of patients in England with primary advanced or recurrent (A/R) endometrial cancer (EC) who may have been eligible for clinical trials evaluating immune checkpoint inhibitors (ICIs) in the first-line (1L) setting within a real-world dataset, and de...
Saved in:
| Main Authors: | Clare Pearson, Susana Banerjee, Kiera Heffernan, Tameera Rahman, Jamie Garside, Alvaro Ingles Russo Garces |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/11/e083540.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Monica Kobayashi, et al.
Published: (2023-11-01) -
Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Robert L. Coleman, et al.
Published: (2023-10-01) -
The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
by: Anže Feguš, et al.
Published: (2024-09-01) -
Real world outcomes in patients with recurrent, advanced, or metastatic endometrial cancer treated with lenvatinib plus pembrolizumab
by: A. Pawsey, et al.
Published: (2025-05-01) -
Epidemiology and survival outcomes for liposarcoma patients in England: An observational cohort study using real world data
by: Jessie O. Oyinlola, et al.
Published: (2025-05-01)